Dow Jones Top Company Headlines at 11 AM ET: Anthropic Unveils Paperwork for Blockbuster IPO | Meta ...
Anthropic Unveils Paperwork for Blockbuster IPO
Anthropic filed its IPO paperwork, known as its S-1 filing, giving the world the first official look at details of its business operations and ownership.
----
Meta Plans up to $95 Billion in Financing to Power Its AI Growth
The Facebook parent said it would look to raise up to $95 billion to help fund its massive investments in artificial-intelligence infrastructure and personal superintelligence.
----
Verizon Lifts Outlook, Inks Amazon Deal Worth More Than $2 Billion
Verizon boosted its full-year outlook again as it continues to attract new customers. The mobile carrier also signed an AI deal valued at more than $2 billion with Amazon.
----
FedEx Hires AutoZone's Jamere Jackson as CFO
FedEx has hired Jamere Jackson as the package-delivery giant's new chief financial officer, plucking the executive from auto-parts retailer AutoZone.
----
EQT to Buy Range Resources in $13 Billion Stock Swap
EQT Corp. has struck a deal to buy Range Resources in a stock swap worth nearly $13 billion that would create a U.S. natural-gas giant.
----
Brazil-Exposed Companies Slide After Surprise Lula Victory
Spanish and Portuguese stocks were especially hard hit by the election result, with shares in Spain's largest bank, Santander, down close to 4%.
----
Saudi Arabia's Sabic Profit Rises Despite Lower Sales Volume
The company-one of the world's largest petrochemical manufacturers-reported an increase in net profit even as regional shipping disruptions weighed on sales volumes.
----
Bayer Gets China Approval for Stroke-Prevention Drug in Global First
The authorization to launch Sunharbo in China is the first approval worldwide for a new class of blood-thinning medicines.
----
Roche Targets Emerging Oncology Market With New Lung-Cancer Drug
The drugmaker expects a pill it is developing to become the new standard treatment for an advanced form of lung cancer, and the company's first shot at an emerging field within the oncology market.
----
AstraZeneca Readies New Portfolio of Targeted Cancer Therapies
AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology market.
----
This German Energy Giant Is an Overlooked AI Bargain
Siemens Energy is outselling GE Vernova on gas turbines.
----
Genmab Shares Jump After Positive Cancer Study Results
The Danish biotech said an experimental drug cut the risk of death and disease progression for ovarian-cancer patients in a late-stage clinical trial.
----
Galp Shares Fall After Moeve Merger-Talks Collapse
The stock fell more than 8% after talks with Moeve on a potential downstream combination broke down, overshadowing earnings growth and a full-year guidance hike.
----
Ingenia Removes Warburg Pincus From Data Room Following Rival $1.55 Billion Offer
The retirement-village operator revoked Warburg Pincus's data-room access after it received a US$1.55 billion takeover offer from AVID Property Group.
(END) Dow Jones Newswires
October 26, 2026 11:15 ET (15:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
2 Undervalued Stocks to Buy With Long-Term Growth Ahead
The Market May Be Too Pessimistic About This 4-Star Dividend Stock
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
Why This Vanguard ETF Is One of the Best
United States